Literature DB >> 9447497

Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients.

M P Caligiuri1, J B Lohr.   

Abstract

Previous studies suggest that many untreated schizophrenia patients exhibit motor disturbances. On the basis of these findings, the authors hypothesized that preexisting extrapyramidal movement disorders may increase the risk of developing neuroleptic-induced parkinsonism (NIP). Thirty-five newly medicated psychotic patients underwent pretreatment clinical and instrumental motor and psychiatric assessments. Posttreatment ratings of parkinsonism were conducted at monthly intervals for the first 3 months and every 3 months thereafter. Thirteen patients (37%) developed NIP. Advanced age and pretreatment extrapyramidal disturbances predicted NIP. Life-table survival curves indicated that patients with pretreatment instrumental rigidity developed clinically significant NIP earlier than those without rigidity. These findings suggest that pretreatment motor dysfunction may be a risk factor for drug-induced parkinsonism, especially among older patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9447497     DOI: 10.1176/jnp.9.4.562

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  5 in total

Review 1.  Motor System Pathology in Psychosis.

Authors:  Sebastian Walther; Vijay A Mittal
Journal:  Curr Psychiatry Rep       Date:  2017-10-30       Impact factor: 5.285

2.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

Review 3.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

4.  Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.

Authors:  Ana Alkelai; Lior Greenbaum; Amihai Rigbi; Kyra Kanyas; Bernard Lerer
Journal:  Psychopharmacology (Berl)       Date:  2009-08-13       Impact factor: 4.530

5.  Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate.

Authors:  Francois-Pierre Joubert; Bonginkosi Chiliza; Robin Emsley; Laila Asmal
Journal:  S Afr J Psychiatr       Date:  2021-01-11       Impact factor: 1.550

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.